PharmaEssentia Corporation (TPE:6446)
Taiwan · Delayed Price · Currency is TWD 725.00
-3.00 (-0.41%)
At close: Feb 11, 2026
PharmaEssentia Market Cap
PharmaEssentia has a market cap or net worth of 268.14 billion as of February 20, 2026. Its market cap has increased by 11.72% in one year.
Market Cap
268.14B
Enterprise Value
247.45B
Revenue
13.82B
Ranking
n/a
PE Ratio
55.99
Stock Price
725.00
Market Cap Chart
Since March 11, 2014, PharmaEssentia's market cap has increased from 39.38B to 268.14B, an increase of 580.83%. That is a compound annual growth rate of 17.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 268.14B | 54.26% |
| Dec 31, 2025 | 173.83B | -15.09% |
| Dec 31, 2024 | 204.73B | 78.68% |
| Dec 29, 2023 | 114.58B | -20.34% |
| Dec 30, 2022 | 143.84B | 84.26% |
| Dec 30, 2021 | 78.07B | 215.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lotus Pharmaceutical | 76.92B |
| Bora Pharmaceuticals | 60.77B |
| Center Laboratories | 29.86B |
| TTY Biopharm Company | 20.81B |
| Grape King Bio | 18.07B |
| Alar Pharmaceuticals | 17.87B |
| ScinoPharm Taiwan | 17.12B |
| Synmosa Biopharma | 16.25B |